Acceleron Pharma Inc.
Acceleron Pharma Inc. is listed today as Acceleron Pharma Inc.: market value, financials and filings are on its company page.
Funding rounds
4 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Sep 2013 | $10 M | No. 4 | $10 to $50 million | equity | SEC | |
| Dec 2011 | $30 M | No. 3 | $10 to $50 million | equity | SEC | |
| Jun 2010 | $10 M | No. 2 | $10 to $50 million | equity, options | SEC | |
| Dec 2009 | $11 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Acceleron Pharma Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2013).
SEC Form D · Sep 2013
The industry group it chose in its notices: Biotechnology.
SEC Form D · Sep 2013
That is all the official record says: Acceleron Pharma Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services of Acceleron Pharma Inc. are on record.
Investors#
27 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Advanced Technology Ventures VII(B), L.P. | Venture capital | not stated | not stated | Held Series A, B, C, D, E and F preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Advanced Technology Ventures VII(C), L.P. | Venture capital | not stated | not stated | Held Series A, B, C, D, E and F preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Advanced Technology Ventures VII LP | Venture capital | not stated | not stated | Held Series A, B, C, D, E and F preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Advanced Technology Ventures VI, L.P. | Venture capital | not stated | not stated | Held Series A, B, C, D, E and F preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Agtc Advisors Fund LP | Fund or asset manager | not stated | not stated | Held Series A, B, C, D and F preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| AGTC Partners, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B, C, D and F preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Applied Genomic Technology Capital Fund LP | Fund or asset manager | not stated | not stated | Held Series A, B, C, D and F preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| ATV Alliance 2003, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B, C, D, E and F preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| ATV Associates VII, L.L.C. | Other | not stated | not stated | Held Series A, B, C, D, E and F preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| ATV Associates VI, L.L.C. | Other | not stated | not stated | Held Series A, B, C, D, E and F preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| ATV Entrepreneurs VII, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B, C, D, E and F preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| ATV Entrepreneurs VI, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B, C, D, E and F preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Celgene Corp /de/ | Company | not stated | not stated | Held Series C-1, E and F preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Flagship Pioneering, LLC | Fund or asset manager | not stated | not stated | Held Series A, B, C, D and F preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| NewcoGen Group, Inc. | Company | not stated | not stated | Held Series A, B, C, D and F preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Orbimed Advisors LLC | Fund or asset manager | not stated | not stated | Held Series B, C, D, E and F preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Orbimed Capital GP II LLC | Fund or asset manager | not stated | not stated | Held Series B, C, D, E and F preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Polaris Venture Management Co IV LLC | Venture capital | not stated | not stated | Held Series A, B, C, D, E and F preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Polaris Venture Partners Entrepreneurs Fund IV LP | Venture capital | not stated | not stated | Held Series A, B, C, D, E and F preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Polaris Venture Partners IV LP | Venture capital | not stated | not stated | Held Series A, B, C, D, E and F preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Tom Maniatis | Person | not stated | not stated | Held Series A, B, C and D preferred stock, director (Form 3, 2013) | SEC Form 3 |
| VEF Management IV, LLC | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Venrock Associates IV L.P. | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Venrock Entrepreneurs Fund IV L.P. | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Venrock Management IV, LLC | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Venrock Partners, L.P. | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Venrock Partners Management, LLC | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 48 investors.
Largest shareholders today
Institutions holding Acceleron Pharma Inc. shares, as of Jun 30, 2026.
Source: SEC Form 13F holdings reports · as of Jun 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| John Knopf | Executive officer | Sep 2013 |
| Kevin F. Mclaughlin | Executive officer | Sep 2013 |
| Matthew L. Sherman | Executive officer | Sep 2013 |
| Robert G. Steininger | Executive officer | Sep 2013 |
| Steven G. Ertel | Executive officer | Sep 2013 |
| Robert L. Steininger | Executive officer | Jan 2012 |
| Steven L. Ertel | Executive officer | Jan 2012 |
| Jasbir Seehra | Executive officer | Jul 2010 |
| Peter Courossi | Executive officer | Jul 2010 |
| Anthony B Evnin | Director | Sep 2013 |
| Edwin M. Kania, Jr. | Director | Sep 2013 |
| George S. Golumbeski | Director | Sep 2013 |
| Jean M. George | Director | Sep 2013 |
| John Knopf | Director | Sep 2013 |
| Joseph S. Zakrzewski | Director | Sep 2013 |
| Richard F. Pops | Director | Sep 2013 |
| Terrance G. Mcguire | Director | Sep 2013 |
| Tom G. Maniatis | Director | Sep 2013 |
| Carl L. Gordon | Director | Jan 2012 |
| Edwin M. Kania | Director | Jan 2012 |
| Tom W. Maniatis | Director | Jan 2012 |
| Wylie W. Vale | Director | Jan 2012 |
| Anthony L. Evnin | Director | Jul 2010 |
| Ed L. Kania | Director | Jul 2010 |
| Jean L. George | Director | Jul 2010 |
| Pat L. Gage | Director | Jul 2010 |
| Richard L. Pops | Director | Jul 2010 |
| Terry L. Mcguire | Director | Jul 2010 |
| Tom L. Maniatis | Director | Jul 2010 |
| Wylie L. Vale | Director | Jul 2010 |
About
Company in Cambridge, United States.